Etxeandia-Ikobaltzeta Itziar, Zhang Yuan, Brundisini Francesca, Florez Ivan D, Wiercioch Wojtek, Nieuwlaat Robby, Begum Housne, Cuello Carlos A, Roldan Yetiani, Chen Ru, Ding Chengyi, Morgan Rebecca L, Riva John J, Zhang Yuqing, Charide Rana, Agarwal Arnav, Balduzzi Sara, Morgano Gian Paolo, Yepes-Nuñez Juan José, Rehman Yasir, Neumann Ignacio, Schwab Nicole, Baldeh Tejan, Braun Cody, Rodríguez María Francisca, Schünemann Holger J
Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.
Department of Pediatrics, University of Antioquia, Medellin, Colombia.
Blood Adv. 2020 Mar 10;4(5):953-968. doi: 10.1182/bloodadvances.2019000462.
Values and preferences relate to the importance that patients place on health outcomes (eg, bleeding, having a deep venous thrombosis) and are essential when weighing benefits and harms in guideline recommendations. To inform the American Society of Hematology guidelines for management of venous thromboembolism (VTE) disease, we conducted a systematic review of patients' values and preferences related to VTE. We searched Medline, Embase, Cochrane Central Register of Controlled Trials, PsycINFO, and the Cumulative Index to Nursing and Allied Health Literature from inception to April of 2018 (PROSPERO-CRD42018094003). We included quantitative and qualitative studies. We followed Grading of Recommendations Assessment, Development and Evaluation (GRADE) guidance for rating the certainty and presenting findings for quantitative research about the relative importance of health outcomes and a grounded theory approach for qualitative thematic synthesis. We identified 14 quantitative studies (2465 participants) describing the relative importance of VTE-related health states in a widely diverse population of patients, showing overall small to important impact on patients' lives (certainty of the evidence from low to moderate). Additionally, evidence from 34 quantitative studies (6424 participants) and 15 qualitative studies (570 participants) revealed that patients put higher value on VTE risk reduction than on the potential harms of the treatment (certainty of evidence from low to moderate). Studies also suggested a clear preference for oral medication over subcutaneous medication (moderate certainty). The observed variability in health state values may be a result of differences in the approaches used to elicit them and the diversity of included populations rather than true variability in values. This finding highlights the necessity to explore the variability induced by different approaches to ascertain values.
价值观和偏好与患者对健康结果(如出血、发生深静脉血栓形成)所赋予的重要性相关,并且在权衡指南推荐中的获益和危害时至关重要。为了为美国血液学会关于静脉血栓栓塞症(VTE)疾病管理的指南提供信息,我们对与VTE相关的患者价值观和偏好进行了系统评价。我们检索了Medline、Embase、Cochrane对照试验中央注册库、PsycINFO以及护理和联合健康文献累积索引,检索时间从建库至2018年4月(PROSPERO-CRD42018094003)。我们纳入了定量和定性研究。我们遵循推荐分级评估、制定和评价(GRADE)指南对确定性进行评级,并呈现关于健康结果相对重要性的定量研究结果,以及采用扎根理论方法进行定性主题综合分析。我们确定了14项定量研究(2465名参与者),这些研究描述了在广泛多样的患者群体中VTE相关健康状态的相对重要性,显示对患者生活的总体影响从小到重要(证据确定性从低到中等)。此外,来自34项定量研究(6424名参与者)和15项定性研究(570名参与者)的证据表明,患者对降低VTE风险的重视程度高于对治疗潜在危害的重视程度(证据确定性从低到中等)。研究还表明,与皮下用药相比,患者明显更倾向于口服药物(中等确定性)。观察到的健康状态价值观的变异性可能是由于用于引出这些价值观的方法不同以及纳入人群的多样性,而不是价值观的真正变异性。这一发现凸显了探索不同方法确定价值观所导致的变异性的必要性。